Premier global vascular surgery meeting in New York

October 20, 2005

October 14, 2005: NEW YORK: The 32nd Annual VEITHsymposiumTM will be held November 17-20, 2005 at the Sheraton New York Hotel & Towers (New York, NY).

VEITHsymposiumTM provides vascular surgeons and other vascular specialists and members of the press with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease.

The 4-day event features rapid-fire presentations from the world's most renowned vascular surgeons with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.

  • Vagus Nerve Stimulation for treatment-resistant depression (TRD) & the role of the vascular surgeon
  • Endovascular repair for Abdominal Aortic Aneurysms (AAA) - The Collected World Experience
  • Popliteal Aneurysms - Interpreting the Vice-President's recent procedure
  • New Technique for Treatment Of Subclavian Vein Thrombosis
  • Lipid Management - New developments for treating the vascular patient
  • Laboratory - Blood test that detects cardiac risk in vascular surgery patients
  • Aortoiliac & Thoracic Aneurysms - Progress and Treatments
  • Deep Venous Thrombosis - New Developments
  • Stroke Prevention - Pharmacological options
  • Carotid Artery Disease - Is an intervention always necessary
  • Carotid Stenting - Embolic Injury to the Brain is the Main Problem
  • Lymphedema - Facts & Myths
  • Peripheral Vascular Disease & the Elderly
  • Wound Care Treatment - for the Diabetic Patient

  • Specialty Status for Vascular Surgery
  • Recent Primary Certificate for Vascular Surgery & Why it is not Enough
  • The Legal Penalty Vascular Surgeons Must Face for not Having an Independent Board
  • Establishing Interventional Standards of Practice & Training
    About VEITHsymposiumTM:
    Now in its fourth decade, VEITHsymposiumTM has been the epicenter of physician education for the global vascular community. This international congress attracts over 2,500 thought leaders in the field. More than 250 international clinician/educators present the latest topics, advances, and data and then validate these concepts through the dynamic interactive faculty/audience exchange that ends each session.

    VEITHsymposiumTM is sponsored by Montefiore Medical Center (Bronx, NY) with CME credit issued by Albert Einstein College of Medicine (Bronx, NY).

    PTM Healthcare Marketing, Inc.

    Related Blood Test Articles from Brightsurf:

    Breakthrough blood test developed for brain tumors
    Genetic mutations that promote the growth of the most common type of adult brain tumors can be accurately detected and monitored in blood samples using an enhanced form of liquid biopsy developed by researchers at Massachusetts General Hospital (MGH).

    A blood test could predict who benefits from immunotherapy
    A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, a treatment option for advanced cancers.

    Diagnosing brain tumors with a blood test
    A simple but highly sensitive blood test has been found to accurately diagnose and classify different types of brain tumours, resulting in more accurate diagnosis, less invasive methods and better treatment planning in the future for the patients.

    Blood test may help predict whose MS will get worse
    A blood test may help predict which people with multiple sclerosis (MS) will get worse during the following year, according to a study published in the May 20, 2020, online issue of Neurology®, the medical journal of the American Academy of Neurology.

    New blood test for Alzheimer's developed
    A new blood test for Alzheimer's disease has been developed under the leadership of researchers at the University of Gothenburg, Sweden.

    Blood test for deadly eye melanoma
    A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.

    Blood test could help to accelerate brain cancer diagnosis
    A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.

    New blood test for detecting Alzheimer's disease
    Researchers from Lund University, together with the Roche pharmaceutical company, have used a method to develop a new blood marker capable of detecting whether or not a person has Alzheimer's disease.

    Coming soon: A blood test for Alzheimer's disease?
    People with symptoms of Alzheimer's disease (AD), such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis.

    Blood test for tau, Alzheimer's disease under development
    Investigators at Brigham and Women's Hospital are working to develop a blood test to accurately diagnose or even predict Alzheimer's disease before symptoms appear.

    Read More: Blood Test News and Blood Test Current Events
  • is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to